Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
Ontology highlight
ABSTRACT: The use of designer benzodiazepines appears to be increasing in many countries, but data concerning blood concentrations are scarce, making interpretation of concentrations difficult. The aim of this study was to report blood concentrations of clonazolam, diclazepam, etizolam, flualprazolam, flubromazepam, flubromazolam and phenazepam and to investigate the relationship between blood concentrations and impairment. The concentration data are from blood samples collected from living cases (apprehended drivers and other drug offences) and medico-legal autopsies. The blood samples were analysed for the seven designer benzodiazepines mentioned above by ultra high performance liquid chromatography-tandem mass spectrometry. Positive cases from between 1 June 2016 and 30 September 2019 were includ
SUBMITTER: Heide G
PROVIDER: S-EPMC7733327 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA